Stock Quote (NASDAQ: VTUS)
Price:
10.50
Change:
- 0.76
Day High:
11.37
Day Low:
10.10
Volume:
300,000
4:00 PM ET on May 18, 2012
Delayed at least 20min., by eSignal.
Corporate Governance

SHAREHOLDER TOOLS
Briefcase Printed Materials Email Alerts
Download Center snapshot RSS Mobile Investor

PROXY STATEMENT
2011 Annual Report
2012 Proxy Statement

The Board of Directors of Ventrus Bioscience, Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Corporate Committee Charters View
Audit Committee Charter HTML PDF   14.7 KB Add to Briefcase
Nominating and Governance Committee Charter HTML PDF   8.8 KB Add to Briefcase
Compensation Committee Charter HTML PDF   10.2 KB Add to Briefcase


Governance Documents View
Insider Trading Policy HTML PDF   23.9 KB Add to Briefcase
Code of Conduct HTML PDF   22.3 KB Add to Briefcase
Whistleblower Policy HTML PDF   9.5 KB Add to Briefcase
Code of Ethics HTML PDF   9.1 KB Add to Briefcase


Add to Briefcase = add file to Briefcase
 
Home About Ventrus Product Pipeline Contact Investor Relations